AAAAAA
Results: 1-25/32
Authors:
OERTEL R
RICHTER K
GRAMATTE T
KIRCH W
Citation: R. Oertel et al., DETERMINATION OF DRUGS IN BIOLOGICAL-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ONLINE SAMPLE PROCESSING, Journal of chromatography, 797(1-2), 1998, pp. 203-209
Authors:
EBERT U
OERTEL R
WESNES KA
KIRCH W
Citation: U. Ebert et al., EFFECTS OF PHYSOSTIGMINE ON SCOPOLAMINE-INDUCED CHANGES IN QUANTITATIVE ELECTROENCEPHALOGRAM AND COGNITIVE PERFORMANCE, Human psychopharmacology, 13(3), 1998, pp. 199-210
Authors:
EBERT U
SIEPMANN M
OERTEL R
WESNES KA
KIRCH W
Citation: U. Ebert et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF SCOPOLAMINE AFTER SUBCUTANEOUS ADMINISTRATION, Journal of clinical pharmacology, 38(8), 1998, pp. 720-726
Authors:
OERTEL R
RICHTER K
Citation: R. Oertel et K. Richter, PLASMA-PROTEIN BINDING OF THE LOCAL-ANESTHETIC DRUG ARTICAINE AND ITSMETABOLITE ARTICAINIC ACID, Die Pharmazie, 53(9), 1998, pp. 646-647
Authors:
OERTEL R
SCHWARZ U
KIRCH W
Citation: R. Oertel et al., IN-VITRO INVESTIGATION OF THE INTERACTION S OF TALINOLOL WITH DIFFERENT ERYTHROMYCIN PREPARATIONS AND SUBSTANCES, Die Pharmazie, 53(4), 1998, pp. 277-278
Authors:
EBERT U
OERTEL R
SICKOR S
KIRCH W
Citation: U. Ebert et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF CNS EFFECTS OF SCOPOLAMINE IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 66-66
Authors:
OERTEL R
RAHN R
KIRCH W
Citation: R. Oertel et al., CLINICAL PHARMACOKINETICS OF ARTICAINE, Clinical pharmacokinetics, 33(6), 1997, pp. 417-425
Authors:
LOESCH DZ
PETROVIC V
FRANCIS DI
OERTEL R
SLATER H
Citation: Dz. Loesch et al., REDUCTION OF CGG TRINUCLEOTIDE EXPANSION FROM MOTHER TO OFFSPRING IN 7 FRAGILE-X FAMILIES, Clinical genetics, 51(1), 1997, pp. 1-6
Authors:
RICHTER K
OERTEL R
KIRCH W
Citation: K. Richter et al., NEW SENSITIVE METHOD FOR THE DETERMINATION OF HYDROCHLOROTHIAZIDE IN HUMAN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION, Journal of chromatography, 729(1-2), 1996, pp. 293-296
Authors:
OERTEL R
RICHTER K
EBERT U
KIRCH W
Citation: R. Oertel et al., DETERMINATION OF SCOPOLAMINE IN HUMAN SERUM BY GAS-CHROMATOGRAPHY ION-TRAP TANDEM MASS-SPECTROMETRY, Journal of chromatography B. Biomedical applications, 682(2), 1996, pp. 259-264
Authors:
OERTEL R
BERNDT A
KIRCH W
Citation: R. Oertel et al., SATURABLE IN-VITRO METABOLISM OF ARTICAINE BY SERUM ESTERASES - DOES IT CONTRIBUTE TO THE PERSISTENCE OF THE LOCAL-ANESTHETIC EFFECT, Regional anesthesia, 21(6), 1996, pp. 576-581
Authors:
GRAMATTE T
OERTEL R
TERHAAG B
KIRCH W
Citation: T. Gramatte et al., DIRECT DEMONSTRATION OF SMALL-INTESTINAL SECRETION AND SITE-DEPENDENTABSORPTION OF THE BETA-BLOCKER TALINOLOL IN HUMANS, Clinical pharmacology and therapeutics, 59(5), 1996, pp. 541-549
Authors:
BERNDT A
GRAMATTE T
OERTEL R
TERHAAG B
RICHTER K
KIRCH W
Citation: A. Berndt et al., DAY-NIGHT VARIATIONS IN THE RENAL EXCRETION OF THE ANTIARRHYTHMIC AGENT TIRACIZINE AND ITS METABOLITES, Chronobiology international, 12(2), 1995, pp. 135-140
Authors:
BERNDT A
HOFFMANN C
RICHTER K
OERTEL R
VIERKANT A
SIEGMUND W
Citation: A. Berndt et al., TIRACIZINE DISPOSITION IN HEALTHY-VOLUNTEERS WITH REFERENCE TO THE DEBRISOQUINE OXIDATION PHENOTYPE, British journal of clinical pharmacology, 40(3), 1995, pp. 287-288
Authors:
TRAUSCH B
OERTEL R
RICHTER K
GRAMATTE T
Citation: B. Trausch et al., DISPOSITION AND BIOAVAILABILITY OF THE BETA(1)-ADRENOCEPTOR ANTAGONIST TALINOLOL IN MAN, Biopharmaceutics & drug disposition, 16(5), 1995, pp. 403-414
Authors:
BERNDT A
OERTEL R
TERHAAG B
RICHTER K
GRAMATTE T
Citation: A. Berndt et al., PHARMACOKINETICS OF THE ANTIARRHYTHMIC AGENT TIRACIZINE - STEADY-STATE KINETICS IN COMPARISON WITH SINGLE-DOSE KINETICS, Biopharmaceutics & drug disposition, 16(5), 1995, pp. 427-441
Authors:
OERTEL R
RICHTER K
Citation: R. Oertel et K. Richter, TALINOLOL METABOLITES IN HUMANS - RELATIO NSHIPS BETWEEN STRUCTURE, POLARITY AND EXCRETED AMOUNT, Die Pharmazie, 50(9), 1995, pp. 637-638
Authors:
TRAUSCH B
OERTEL R
RICHTER K
GRAMATTE T
Citation: B. Trausch et al., THE PROTEIN-BINDING OF TALINOLOL, Die Pharmazie, 50(1), 1995, pp. 72-72
Authors:
OERTEL R
KONIETZKO N
Citation: R. Oertel et N. Konietzko, CYANOSIS, Der Internist, 36(10), 1995, pp. 1019-1030
Authors:
BERNDT A
OERTEL R
RICHTER K
TERHAAG B
GRAMATTE T
Citation: A. Berndt et al., RELATIVE BIOAVAILABILITY OF THE ANTIARRHY THMIC AGENT TIRACIZINE AND 3 OF ITS METABOLITES, Arzneimittel-Forschung, 45-1(3), 1995, pp. 250-253
Authors:
DOBREV D
BERNDT A
OERTEL R
RICHTER K
TERHAAG B
GRAMATTE T
Citation: D. Dobrev et al., BIOEQUIVALENCE OF METOCLOPRAMIDE IN 2 TAB LET FORMULATIONS, Arzneimittel-Forschung, 45-1(3), 1995, pp. 304-306
Authors:
OERTEL R
RICHTER K
TRAUSCH B
BERNDT A
GRAMATTE T
KIRCH W
Citation: R. Oertel et al., ELUCIDATION OF THE STRUCTURE OF TALINOLOL METABOLITES IN MAN - DETERMINATION OF TALINOLOL AND HYDROXYLATED TALINOLOL METABOLITES IN URINE AND ANALYSIS OF TALINOLOL IN SERUM, Journal of chromatography B. Biomedical applications, 660(2), 1994, pp. 353-363
Authors:
OERTEL R
RICHTER K
TRAUSCH B
BERNDT A
GRAMATTE T
KIRCH W
Citation: R. Oertel et al., ELUCIDATION OF THE STRUCTURE OF TALINOLOL METABOLITES IN MAN - DETERMINATION OF TALINOLOL AND HYDROXYLATED TALINOLOL METABOLITES IN URINE AND ANALYSIS OF TALINOLOL IN SERUM, Journal of chromatography B. Biomedical applications, 660(2), 1994, pp. 353-363
Authors:
BERNDT A
GRAMATTE T
OERTEL R
RICHTER K
TERHAAG B
KIRCH W
Citation: A. Berndt et al., DOSE-DEPENDENT TIRACIZINE DISPOSITION IN HEALTHY-VOLUNTEERS - SERUM AND URINE KINETICS AND DOSE-RELATED ECG-CHANGES, European journal of drug metabolism and pharmacokinetics, 19(4), 1994, pp. 359-368
Authors:
SCHMIDT B
OERTEL R
Citation: B. Schmidt et R. Oertel, VDI-GVC MEETING ON INNOVATION DYNAMICS IN -PROCESS ANALYSIS, AUTOMATION TECHNOLOGY AND CHEMICAL-ENGINEERING IN THE CHEMICAL-INDUSTRY, Chemische Technik, 46(2), 1994, pp. 109-110